{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:56:48Z","timestamp":1778273808478,"version":"3.51.4"},"reference-count":50,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-2009-2.2.1-3\/242114 (Project OPTiMiSE)"],"award-info":[{"award-number":["HEALTH-2009-2.2.1-3\/242114 (Project OPTiMiSE)"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-2013-2.4.2-1\/602936 (Project CarTarDis)"],"award-info":[{"award-number":["HEALTH-2013-2.4.2-1\/602936 (Project CarTarDis)"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG; RA 459\/3-1"],"award-info":[{"award-number":["DFG; RA 459\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007273","name":"Weill Cornell Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:p>Metformin is the first-line oral medication to increase insulin sensitivity in patients with type 2 diabetes (T2D). Our aim was to investigate the pleiotropic effect of metformin using a nontargeted metabolomics approach. We analyzed 353 metabolites in fasting serum samples of the population-based human KORA (Cooperative Health Research in the Region of Augsburg) follow-up survey 4 cohort. To compare T2D patients treated with metformin (mt-T2D, n = 74) and those without antidiabetes medication (ndt-T2D, n = 115), we used multivariable linear regression models in a cross-sectional study. We applied a generalized estimating equation to confirm the initial findings in longitudinal samples of 683 KORA participants. In a translational approach, we used murine plasma, liver, skeletal muscle, and epididymal adipose tissue samples from metformin-treated db\/db mice to further corroborate our findings from the human study. We identified two metabolites significantly (P &amp;lt; 1.42E-04) associated with metformin treatment. Citrulline showed lower relative concentrations and an unknown metabolite X-21365 showed higher relative concentrations in human serum when comparing mt-T2D with ndt-T2D. Citrulline was confirmed to be significantly (P &amp;lt; 2.96E-04) decreased at 7-year follow-up in patients who started metformin treatment. In mice, we validated significantly (P &amp;lt; 4.52E-07) lower citrulline values in plasma, skeletal muscle, and adipose tissue of metformin-treated animals but not in their liver. The lowered values of citrulline we observed by using a nontargeted approach most likely resulted from the pleiotropic effect of metformin on the interlocked urea and nitric oxide cycle. The translational data derived from multiple murine tissues corroborated and complemented the findings from the human cohort.<\/jats:p>","DOI":"10.2337\/db16-0512","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T01:48:34Z","timestamp":1473731314000},"page":"3776-3785","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":56,"title":["Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues"],"prefix":"10.2337","volume":"65","author":[{"given":"Jonathan","family":"Adam","sequence":"first","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Brandmaier","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Leonhardt","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus F.","family":"Scheerer","sequence":"additional","affiliation":[{"name":"Institute of Experimental Genetics, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Mohney","sequence":"additional","affiliation":[{"name":"Metabolon, Inc., Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Rotter","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Troll","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Chi","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Heier","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Herder","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rathmann","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Giani","sequence":"additional","affiliation":[{"name":"Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Adamski","sequence":"additional","affiliation":[{"name":"Institute of Experimental Genetics, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Experimental Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universit\u00e4t M\u00fcnchen, Freising, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[{"name":"Hannover Unified Biobank, Hannover Medical School, Hannover, Germany"},{"name":"Institute for Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Strauch","sequence":"additional","affiliation":[{"name":"Institute of Genetic Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Genetic Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixue","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gieger","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Peters","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"Department of Environmental Health, Harvard School of Public Health, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Suhre","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Faculty of Biology, Ludwig-Maximilians-Universit\u00e4t, Planegg-Martinsried, Germany"},{"name":"Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar (WCMC-Q), Education City\u2013Qatar Foundation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Ankerst","sequence":"additional","affiliation":[{"name":"Lehrstuhl f\u00fcr Mathematische Modelle Biologischer Systeme, Technische Universit\u00e4t M\u00fcnchen, Garching, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meitinger","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Human Genetics, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hrab\u0115 de Angelis","sequence":"additional","affiliation":[{"name":"Institute of Experimental Genetics, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"Institute of Experimental Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universit\u00e4t M\u00fcnchen, Freising, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"},{"name":"ShanghaiTech University, Shanghai, China"},{"name":"Department of Endocrinology and Diabetology, Medical Faculty, D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Neschen","sequence":"additional","affiliation":[{"name":"Institute of Experimental Genetics, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang-Sattler","sequence":"additional","affiliation":[{"name":"Research Unit of Molecular Epidemiology, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"2022031300473753200_B1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"key":"2022031300473753200_B2","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2022031300473753200_B3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/diacare.16.10.1387","article-title":"Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women","volume":"16","author":"Giugliano","year":"1993","journal-title":"Diabetes Care"},{"key":"2022031300473753200_B4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/db14-0393","article-title":"Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice","volume":"64","author":"Neschen","year":"2015","journal-title":"Diabetes"},{"key":"2022031300473753200_B5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"2022031300473753200_B6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/dc15-0658","article-title":"Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes","volume":"38","author":"Xu","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031300473753200_B7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031300473753200_B8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-5793(98)01705-0","article-title":"AMP-activated protein kinase phosphorylation of endothelial NO synthase","volume":"443","author":"Chen","year":"1999","journal-title":"FEBS Lett"},{"key":"2022031300473753200_B9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/diabetes.55.02.06.db05-1064","article-title":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase","volume":"55","author":"Davis","year":"2006","journal-title":"Diabetes"},{"key":"2022031300473753200_B10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.celrep.2016.04.024","article-title":"Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes","volume":"15","author":"Konopka","year":"2016","journal-title":"Cell Reports"},{"key":"2022031300473753200_B11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jpba.2009.01.008","article-title":"Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride","volume":"49","author":"Huo","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"2022031300473753200_B12","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.metabol.2013.07.003","article-title":"Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus","volume":"62","author":"Walford","year":"2013","journal-title":"Metabolism"},{"key":"2022031300473753200_B13","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.2337\/dci15-0022","article-title":"Response to comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858\u20131867","volume":"38","author":"Brandmaier","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031300473753200_B14"},{"key":"2022031300473753200_B15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.metabol.2015.01.008","article-title":"Effect of insulin sensitizer therapy on amino acids and their metabolites","volume":"64","author":"Irving","year":"2015","journal-title":"Metabolism"},{"key":"2022031300473753200_B16","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"2022031300473753200_B17","doi-asserted-by":"crossref","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","article-title":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting","volume":"5","author":"Suhre","year":"2010","journal-title":"PLoS One"},{"key":"2022031300473753200_B18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fphar.2016.00135","article-title":"Pharmacometabolomic assessment of metformin in non-diabetic, African Americans","volume":"7","author":"Rotroff","year":"2016","journal-title":"Front Pharmacol"},{"key":"2022031300473753200_B19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1464-5491.2010.03065.x","article-title":"Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4\/F4 cohort study","volume":"27","author":"Rathmann","year":"2010","journal-title":"Diabet Med"},{"key":"2022031300473753200_B20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1464-5491.2009.02905.x","article-title":"Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study","volume":"27","author":"Meisinger","year":"2010","journal-title":"Diabet Med"},{"key":"2022031300473753200_B21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"2022031300473753200_B22","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal Chem"},{"key":"2022031300473753200_B23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0192623309336152","article-title":"Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats","volume":"37","author":"Ohta","year":"2009","journal-title":"Toxicol Pathol"},{"key":"2022031300473753200_B24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10354","article-title":"Human metabolic individuality in biomedical and pharmaceutical research","volume":"477","author":"Suhre","year":"2011","journal-title":"Nature"},{"key":"2022031300473753200_B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11306-013-0565-2","article-title":"Metabolite profiling reveals new insights into the regulation of serum urate in humans","volume":"10","author":"Albrecht","year":"2014","journal-title":"Metabolomics"},{"key":"2022031300473753200_B26","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2022031300473753200_B27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites","volume":"46","author":"Shin","year":"2014","journal-title":"Nat Genet"},{"key":"2022031300473753200_B28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1474-9726.2012.00865.x","article-title":"Human serum metabolic profiles are age dependent","volume":"11","author":"Yu","year":"2012","journal-title":"Aging Cell"},{"key":"2022031300473753200_B29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1741-7015-11-60","article-title":"Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"key":"2022031300473753200_B30"},{"key":"2022031300473753200_B31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10654-014-9910-7","article-title":"Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism","volume":"29","author":"Altmaier","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2022031300473753200_B32","doi-asserted-by":"crossref","first-page":"e40009","DOI":"10.1371\/journal.pone.0040009","article-title":"Body fat free mass is associated with the serum metabolite profile in a population-based study","volume":"7","author":"Jourdan","year":"2012","journal-title":"PLoS One"},{"key":"2022031300473753200_B33"},{"key":"2022031300473753200_B34","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2022031300473753200_B35"},{"key":"2022031300473753200_B36","doi-asserted-by":"crossref","first-page":"D199","DOI":"10.1093\/nar\/gkt1076","article-title":"Data, information, knowledge and principle: back to metabolism in KEGG","volume":"42","author":"Kanehisa","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2022031300473753200_B37","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2022031300473753200_B38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","article-title":"Almost all about citrulline in mammals","volume":"29","author":"Curis","year":"2005","journal-title":"Amino Acids"},{"key":"2022031300473753200_B39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1432-1033.1987.tb13489.x","article-title":"Primary and quaternary structure of the catabolic ornithine carbamoyltransferase from Pseudomonas aeruginosa. Extensive sequence homology with the anabolic ornithine carbamoyltransferases of Escherichia coli","volume":"166","author":"Baur","year":"1987","journal-title":"Eur J Biochem"},{"key":"2022031300473753200_B40","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"2022031300473753200_B41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.ATV.0000221230.08596.98","article-title":"AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress","volume":"26","author":"Zhang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031300473753200_B42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02918387","article-title":"Elevated urinary nitrite and citrulline levels in patients with rheumatoid arthritis","volume":"7","author":"Wanchu","year":"1999","journal-title":"Inflammopharmacology"},{"key":"2022031300473753200_B43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/niox.2000.0309","article-title":"Increased nitric oxide production in patients with systemic sclerosis","volume":"4","author":"Sud","year":"2000","journal-title":"Nitric Oxide"},{"key":"2022031300473753200_B44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fphys.2013.00321","article-title":"Adrenoreceptors and nitric oxide in the cardiovascular system","volume":"4","author":"Conti","year":"2013","journal-title":"Front Physiol"},{"key":"2022031300473753200_B45","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.2337\/db09-1772","article-title":"Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy","volume":"59","author":"Tessari","year":"2010","journal-title":"Diabetes"},{"key":"2022031300473753200_B46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3466.2006.00275.x","article-title":"Therapeutic use of citrulline in cardiovascular disease","volume":"24","author":"Romero","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"2022031300473753200_B47","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","article-title":"Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle","volume":"270","author":"Husson","year":"2003","journal-title":"Eur J Biochem"},{"key":"2022031300473753200_B48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"2022031300473753200_B49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jchromb.2011.10.018","article-title":"LC-MS-based metabolomics in the clinical laboratory","volume":"883-884","author":"Becker","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2022031300473753200_B50","doi-asserted-by":"crossref","first-page":"e21230","DOI":"10.1371\/journal.pone.0021230","article-title":"Differences between human plasma and serum metabolite profiles","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db16-0512","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/65\/12\/3776\/417865\/db160512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/12\/3776\/417865\/db160512.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:30:38Z","timestamp":1667406638000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/12\/3776\/35036\/Metformin-Effect-on-Nontargeted-Metabolite"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,9,12]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db16-0512","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}